SCHEMBL18029547

SCHEMBL18029547

CCc1nc2ccccc2n1-c1ccc(-c2cc3ccccc3c3c2oc2ccc4ccccc4c23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 6/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ RECQL P46063 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ PSMD14 O00487 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ SIRT2 Q8IXJ6 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ PTGER4 P35408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18029549 0.90 PDE10A (0.39) PDE10ACYP1A2ALDH1A1KDM4EMEN1
SCHEMBL24108459 0.87 ESR1 (0.49) CYP1A2ALDH1A1KDM4EMEN1MAPT
SCHEMBL25787162 0.86 ESR1 (0.44) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL12912438 0.85 PDE10A (0.41) PDE10ACYP1A2ALDH1A1KDM4EMEN1
SCHEMBL9976882 0.84 PDE10A (0.43) PDE10ACYP1A2ALDH1A1KDM4EMEN1
SCHEMBL15394376 0.83 ALDH1A1 (0.42) PDE10ACYP1A2ALDH1A1KDM4EMEN1
SCHEMBL15394602 0.82 ALDH1A1 (0.41) PDE10ACYP1A2ALDH1A1KDM4EMEN1
SCHEMBL18029493 0.82 AHR (0.41) CYP1A2KDM4EL3MBTL1ESR1ESR2
SCHEMBL18717961 0.82 KDM4E (0.41) CYP1A2ALDH1A1KDM4EMEN1MAPT
SCHEMBL20864881 0.81 ALDH1A1 (0.39) PDE10ACYP1A2ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3259786-B1 SEMICONDUCTING MATERIAL AND NAPHTOFURANE MATRIX COMPOUND FOR IT NOVALED GMBH (DE) 2023-08-30 — — EP disclosed
US-11362285-B2 Semiconducting material and naphthofurane matrix compound for it NOVALED GMBH (DE) 2022-06-14 — — US disclosed
US-20200280002-A1 Semiconducting Material and Naphthofurane Matrix Compound for It NOVALED GMBH (DE) 2020-09-03 — — US disclosed
US-10658599-B2 Semiconducting material and naphthofurane matrix compound for it NOVALED GMBH (DE) 2020-05-19 — — US disclosed
US-20180076397-A1 Semiconducting Material and Naphtofurane Matrix Compound for It NOVALED GMBH (DE) 2018-03-15 — — US disclosed
US-20180076397-A1 Semiconducting Material and Naphtofurane Matrix Compound for It NOVALED GMBH (DE) 2018-03-15 — — US disclosed
WO-2016131918-A1 SEMICONDUCTING MATERIAL AND NAPHTOFURANE MATRIX COMPOUND FOR IT NOVALED GMBH (DE) 2016-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200280002-A1 Semiconducting Material and Naphthofurane Matrix Compound for It NES, NQO1, VIM PDE10A 3617/4885CYP1A2 1253/4885ALDH1A1 1096/4885
US-10658599-B2 Semiconducting material and naphthofurane matrix compound for it NES, NQO1, VIM PDE10A 3617/4885CYP1A2 1253/4885ALDH1A1 1096/4885
US-11362285-B2 Semiconducting material and naphthofurane matrix compound for it NES, NQO1, VIM PDE10A 3617/4885CYP1A2 1253/4885ALDH1A1 1096/4885
US-20180076397-A1 Semiconducting Material and Naphtofurane Matrix Compound for It NAPRT, NES, NAMPT PDE10A 3475/4885CYP1A2 904/4885ALDH1A1 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback